Martin Shkreli. Valeant Pharmaceuticals. Mylan. These names have become big news, but just a year ago, most Americans devoted little time and attention to the question of pharmaceutical pricing. Now, a Kaiser Health Tracking Poll released Oct. 27 suggests many people care more about the increasing prices of drugs than they do about any other aspect of health care reform

Quick Read

An overwhelming majority of Americans favor government action to restrain prescription drug prices, according to a poll released Thursday

Quick Read

Privately insured people with cancer were diagnosed earlier and lived longer than those who were uninsured or were covered by Medicaid, according to two recent studies

Quick Read

The unrelenting struggle of raising Brazil’s Zika babies. Baby Duda sat in bed, a pink barrette in her hair. She was ready to go home after a month in the hospital — when she began gasping for breath. Nurses rushed to her side with emergency oxygen

Quick Read

Amid a raging opioid epidemic, many doctors and families in the U.S. have been pleading for better treatment alternatives. One option now under consideration by the Food and Drug Administration is a system of implanted rods that offer controlled release of buprenorphine — a drug already used in other forms to treat opioid addiction

Quick Read

Doctors at the University Hospitals of Cleveland see an immediately recognizable symbol pop up alongside certain drugs when they sign in online these days to prescribe medications for patients: $$$$$

Quick Read

The U.S. Supreme Court ruled that states cannot require many large employers to submit health care claims to a massive database. Here’s why that matters

Quick Read

One of the missions of the 2010 federal health law is to slow the soaring cost of health care. A key strategy for Medicare is encouraging doctors, hospitals and other health care providers to form accountable care organizations (ACOs) to coordinate beneficiaries’ care and provide services more efficiently

Quick Read